Tower Microneedle Via Reverse Drawing Lithography for Innocuous Intravitreal Drug Delivery

The "tower microneedle" (TM) via reverse drawing lithography for intravitreal injection by fabricating a long hollow microneedle on the blunt hypodermic needle: The hollow hole between the microneedle and hypodermic needle is aligned concentrically, and fifteen degree bevel angle is introduced to TM by laser cutting to achieve intravitreal injection with minimal damage to eye tissue.

[1]  Jung Dong Kim,et al.  A high-capacity, hybrid electro-microneedle for in-situ cutaneous gene transfer. , 2011, Biomaterials.

[2]  Hyungil Jung,et al.  Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose. , 2011, Biomaterials.

[3]  Mark R. Prausnitz,et al.  Intrascleral Drug Delivery to the Eye Using Hollow Microneedles , 2009, Pharmaceutical Research.

[4]  A. Urtti,et al.  Current and future ophthalmic drug delivery systems. A shift to the posterior segment. , 2008, Drug discovery today.

[5]  M. Prausnitz,et al.  Coated microneedles for drug delivery to the eye. , 2007, Investigative ophthalmology & visual science.

[6]  A. Mitra,et al.  Novel approaches to retinal drug delivery , 2007, Expert opinion on drug delivery.

[7]  J. Hsu,et al.  Drug delivery methods for posterior segment disease , 2007, Current opinion in ophthalmology.

[8]  Clive G. Wilson,et al.  Topical and systemic drug delivery to the posterior segments. , 2005, Advanced drug delivery reviews.

[9]  A. Urtti,et al.  Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. , 2005, Investigative ophthalmology & visual science.

[10]  L. Aiello,et al.  RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW , 2004, Retina.

[11]  Sridhar Duvvuri,et al.  Drug delivery to the retina: challenges and opportunities , 2003, Expert opinion on biological therapy.

[12]  D. Maurice,et al.  Review: practical issues in intravitreal drug delivery. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[13]  A. Urtti,et al.  Controlled Ocular Timolol Delivery: Systemic Absorption and Intraocular Pressure Effects in Humans , 1994, Pharmaceutical Research.

[14]  A. Urtti,et al.  Controlled drug delivery devices for experimental ocular studies with timolol 2. Ocular and systemic absorption in rabbits , 1990 .

[15]  M. Prausnitz,et al.  Suprachoroidal Drug Delivery to the Back of the Eye Using Hollow Microneedles , 2010, Pharmaceutical Research.